WO2013105688A1 - Method for preparing 1-(1'-(carboxymethyl)cyclopropane methyl disulfonyl methyl)cyclopropane acetic acid and derivative thereof - Google Patents

Method for preparing 1-(1'-(carboxymethyl)cyclopropane methyl disulfonyl methyl)cyclopropane acetic acid and derivative thereof Download PDF

Info

Publication number
WO2013105688A1
WO2013105688A1 PCT/KR2012/000925 KR2012000925W WO2013105688A1 WO 2013105688 A1 WO2013105688 A1 WO 2013105688A1 KR 2012000925 W KR2012000925 W KR 2012000925W WO 2013105688 A1 WO2013105688 A1 WO 2013105688A1
Authority
WO
WIPO (PCT)
Prior art keywords
cyclopropane
methyl
carboxymethyl
acetic acid
ester
Prior art date
Application number
PCT/KR2012/000925
Other languages
French (fr)
Korean (ko)
Inventor
조양래
정선이
허정희
유혜리
손효빈
한나라
지고운
박정배
Original Assignee
(주)위즈켐
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)위즈켐 filed Critical (주)위즈켐
Publication of WO2013105688A1 publication Critical patent/WO2013105688A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/14Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00Other general methods
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/22Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/22Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides
    • C07C319/24Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides by reactions involving the formation of sulfur-to-sulfur bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/02Monothiocarboxylic acids
    • C07C327/14Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00Thiocarbonic acids; Halides, esters or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30Isothioureas
    • C07C335/32Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Definitions

  • the present invention relates to 1- (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl), which is a precursor of intermediate 1- (mercaptomethyl) cyclopropaneacetic acid, which is important in the synthesis of pharmaceuticals, in particular the asthma drug' Montelukast ' It relates to a method for producing cyclopropane acetic acid (1) and derivatives thereof ((2), (3)].
  • the intermediate in order to overcome the industrial difficulties of the existing process, the intermediate is reacted with disodium disulfide (Na 2 S 2 ) which can be manufactured very easily from the intermediate (8), which is easy to manufacture, as in Scheme 2.
  • disodium disulfide Na 2 S 2
  • the disulfide compound of (9) it was hydrolyzed to develop a novel production method for simply preparing the target compound (1).
  • X in Scheme 2 includes halogen atoms such as chlorine, bromine, iodine or sulfonate groups such as methanesulfonate, toluenesulfonate that are easily released in substitution reaction with disodium disulfide.
  • Y is a carboxylic acid derivative such as a cyano group or an ester group
  • the ester group includes ester groups which are easily hydrolyzed, such as methyl ester, lower alkyl ester such as ethyl ester or aryl ester such as phenyl ester if necessary.
  • the present invention provides an efficient precursor 1- (1 '-(carboxymethyl) cyclopropanemethyl that makes it easy to prepare 1- (mercaptomethyl) cyclopropaneacetic acid, which is a major ingredient in the manufacture of medicines such as montelukast.
  • Disulfanylmethyl) cyclopropaneacetic acid and its derivatives are useful inventions that facilitate the industrial production of pharmaceuticals such as the asthma drug 'montelukast' by providing a novel manufacturing process that can effectively prepare them.
  • the present invention provides a disulfide compound of the following formula (9) by reacting a cyclopropaneacetic acid derivative of the following formula (8) with disodium disulfide (Na 2 S 2 ), and alkali hydrolysis of the formula (1)
  • a disulfide compound of the following formula (9) by reacting a cyclopropaneacetic acid derivative of the following formula (8) with disodium disulfide (Na 2 S 2 ), and alkali hydrolysis of the formula (1)
  • X is a halogen atom such as chlorine, bromine or iodine or sulfonate groups such as methanesulfonate and toluenesulfonate which are easily released in substitution reaction with disodium disulfide
  • Y is carboxy such as cyan group or ester group
  • the ester group includes ester groups that are easily hydrolyzed, such as lower alkyl esters such as methyl ester and ethyl ester or aryl esters such as phenyl ester if necessary.
  • Solvents used in the substitution reaction of disodium disulfide include polar organic solvents such as dimethylformamide, dimethyl sulfoxide, tetrahydrofuran and dioxane, alcohols such as methanol and ethanol, nitriles such as acetonitrile and ketones such as acetone. Or mixed solvents of these organic solvents or mixed solvents with water.
  • X in Scheme 3 includes halogen atoms such as chlorine, bromine and iodine or sulfonate groups such as methanesulfonate and toluenesulfonate that are easily released in substitution with disodium disulfide.
  • Y refers to derivatives of organic acids such as esters and cyan groups
  • esters include alkyl esters and aryl esters which are easily hydrolyzed as inorganic bases such as caustic soda, sodium carbonate, potassium hydroxide and potassium carbonate.
  • alkyl esters industrially easy to handle alkyl esters having 1 to 6 carbon atoms are advantageous, and in the case of aryl esters, industrially easy to handle phenyl or substituted phenyl esters are advantageous.
  • Sodium disulfide used in the present invention is a commercially available sodium sulfide hydrate (Na 2 S 2 .7H 2 0) and sulfur using the manufacturing method mentioned in 'Journal of the chemical society 1930. 1473 ⁇ 1497'. It was prepared by heating the reaction under ethanol solvent.
  • the organic layer was neutralized to pH 7-8 with 5% aqueous sodium hydroxide solution, the layers were separated, the organic layer was washed with 100 ml of H 2 O, the organic layer was removed with anhydrous forget-me-not, filtered and the filtrate was concentrated under reduced pressure. 23.4 g (0.124 mol) of 1- (methanesulfonyloxymethyl) cyclopropaneacetonitrile as a light off-white liquid were obtained.
  • the 1- (1 '-(carbomethoxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropane acetic acid methyl ester concentrate obtained in Example 2 was dissolved in 70 ml of methanol, and caustic soda 3.1 g (0.078 mol) was added to reflux for 6 hours. Stirring reaction. When gas chromatography confirmed that the reaction product was consumed, 100 ml of ethyl acetate and 200 ml of water were added thereto, stirred for 30 minutes, and the layers were separated. 150 ml of dichloromethane was added to the separated water layer and neutralized with 5% aqueous hydrochloric acid solution to pH 3-4.
  • This methyl 1- (bromomethyl) cyclopropane acetate concentrate and 3.3 g (0.03 mol) of disodium disulfide were added to 130 ml of DMF and stirred at 90 ° C. for about 8 hours. Confirm the completion of the reaction by gas chromatography analysis, adjust the pH to 3-4 with 5% hydrochloric acid aqueous solution, and neutralize the separated organic layer to pH 7-8 with 5% aqueous sodium hydroxide solution.
  • the present invention relates to 1- (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl), which is a precursor of intermediate 1- (mercaptomethyl) cyclopropaneacetic acid, which is important in the synthesis of pharmaceuticals, in particular the asthma drug' Montelukast ' It can be usefully used to prepare cyclopropane acetic acid and its derivatives.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a novel method for preparing 1-(1'-(carboxymethyl)cyclopropane methyl disulfonyl methyl)cyclopropane acetic acid and derivatives thereof which are precursors of 1-(mercaptomethyl)cyclopropane acetic acid, an important material for the synthesis of a pharmaceutical - especially Montelukast which is an antiasthmatic - in an industrially efficient way. The present invention provides a novel method for preparing 1-(1'-(carboxymethyl)cyclopropane methyl disulfonyl methyl)cyclopropane acetic acid and derivatives thereof characterized by reacting disodium disulfide salt with cyclopropane acetic acid derivatives appropriate for substitution by a mercapto group.

Description

1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산과 그 유도체의 제조방법1- (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropaneacetic acid and its derivative
본 발명은 의약품, 특히 천식치료제 ‘몬테루카스트(Montelukast)'의 합성에서 중요한 중간체 1-(머캅토메틸)시클로프로판아세트산의 전구체인 1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산 (1)과 이의 유도체들[(2),(3)]의 제조방법에 관한 것이다.The present invention relates to 1- (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl), which is a precursor of intermediate 1- (mercaptomethyl) cyclopropaneacetic acid, which is important in the synthesis of pharmaceuticals, in particular the asthma drug' Montelukast ' It relates to a method for producing cyclopropane acetic acid (1) and derivatives thereof ((2), (3)].
Figure PCTKR2012000925-appb-I000001
Figure PCTKR2012000925-appb-I000001
상기 구조식(1)의 1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산의 제조에 관련한 종래의 방법은 미국특허 제6512140에 기술되어 있는데, 이 방법에 의하면 하기 반응식 1에서와 같이 구조식(4)의 1-(히드록시메틸)시클로프로판아세토니트릴을 브롬산과 같은 무기산 존재하에서 교반하여 구조식(5)의 이미노에스테르나 구조식(6)과 같은 브로모아미드 화합물을 만들고 이들 혼합물을 티오우레아와 반응시켜 구조식(7)의 ‘카바이미도설파닐 아미드 염’을 제조 분리하고 이를 알칼리 가수분해한 다음 과산화수소수로 산화반응시키고 중화하여 목적화합물 1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산 (1)을 제조할 수 있다고 발표하였다.Conventional methods related to the preparation of 1- (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropane acetic acid of the above formula (1) are described in US Pat. No. 6,512,140. As in 1, 1- (hydroxymethyl) cyclopropaneacetonitrile of formula (4) is stirred in the presence of an inorganic acid such as bromic acid to form an iminoester of formula (5) or a bromoamide compound of formula (6) These mixtures were reacted with thiourea to prepare and separate the 'carbaimidosulfanyl amide salt' of formula (7), alkali hydrolyze them, oxidize with hydrogen peroxide and neutralize the target compound 1- (1 '-(carboxymethyl). It was reported that cyclopropanemethyldisulfanylmethyl) cyclopropaneacetic acid (1) can be prepared.
<반응식 1><Scheme 1>
Figure PCTKR2012000925-appb-I000002
Figure PCTKR2012000925-appb-I000002
그러나 이 제조공정에서는 부산물 생성을 억제하기 위하여 공업적으로 적용에 어려움이 있는 무수 브롬산의 무수조건 반응이 요구되고 전반적으로 제조공정이 길어서 수율이 대체로 저조하여 공업적으로는 효율성의 면에서 많은 개선이 필요하다.However, in this manufacturing process, anhydrous reaction of bromic anhydride, which is difficult to apply industrially, is required to suppress the formation of by-products, and the overall manufacturing process is long, so that the yield is generally low. This is necessary.
기존 공정의 이러한 공업적 어려움을 극복하고자 본 발명에서는 반응식 2에서와 같이 제조가 용이한 중간체 (8)로부터 공업적으로 매우 쉽게 제조할 수 있는 디소듐 디설파이드(Na2S2)로 치환 반응하여 중간체(9)의 디설파이드 화합물을 합성한 후 이를 가수분해하여 목적 화합물 (1)을 간단하게 제조하는 신규의 제조법을 개발하였다.In the present invention, in order to overcome the industrial difficulties of the existing process, the intermediate is reacted with disodium disulfide (Na 2 S 2 ) which can be manufactured very easily from the intermediate (8), which is easy to manufacture, as in Scheme 2. After the synthesis of the disulfide compound of (9), it was hydrolyzed to develop a novel production method for simply preparing the target compound (1).
<반응식 2><Scheme 2>
Figure PCTKR2012000925-appb-I000003
Figure PCTKR2012000925-appb-I000003
반응식 2에서 X는 디소듐 디설파이드와의 치환 반응에서 이탈이 용이한 염소, 브롬, 요오드와 같은 할로겐 원자 또는 메탄설포네이트, 톨루엔설포네이트와 같은 설포네이트기를 포함한다.X in Scheme 2 includes halogen atoms such as chlorine, bromine, iodine or sulfonate groups such as methanesulfonate, toluenesulfonate that are easily released in substitution reaction with disodium disulfide.
반응식 2에서 Y는 시아노기 또는 에스테르기와 같은 카복시 산 유도체로서 에스테르기는 메틸에스테르, 에틸에스테르와 같은 저급 알킬 에스테르이거나 필요시 페닐에스테르와 같은 아릴에스테르 등과 같이 가수분해가 용이한 에스테르기들을 포함한다.In Scheme 2, Y is a carboxylic acid derivative such as a cyano group or an ester group, and the ester group includes ester groups which are easily hydrolyzed, such as methyl ester, lower alkyl ester such as ethyl ester or aryl ester such as phenyl ester if necessary.
본 발명은 천식치료제 ‘몬테루카스트 (Montelukast)'와 같은 의약품 제조에 있어서 주원료인 1-(머캅토메틸)시클로프로판아세트산을 쉽게 제조하게 하는 효율성있는 전구체 1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산과 이의 유도체들을 효과적으로 제조할 수 있는 신규의 제조 공정을 제공함으로서 천식치료제 ‘몬테루카스트’와 같은 의약품의 대량 생산을 산업적으로 용이하게 하는 유용한 발명이다.The present invention provides an efficient precursor 1- (1 '-(carboxymethyl) cyclopropanemethyl that makes it easy to prepare 1- (mercaptomethyl) cyclopropaneacetic acid, which is a major ingredient in the manufacture of medicines such as montelukast. Disulfanylmethyl) cyclopropaneacetic acid and its derivatives are useful inventions that facilitate the industrial production of pharmaceuticals such as the asthma drug 'montelukast' by providing a novel manufacturing process that can effectively prepare them.
본 발명은 하기 구조식(8)의 시클로프로판아세트산 유도체를 디소듐 디설파이드(Na2S2)와 반응시켜 하기 구조식 (9)의 디설파이드 화합물을 제조하고 이를 알칼리 가수분해하는 것을 특징으로 하는 구조식(1)의 1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산의 제조방법: The present invention provides a disulfide compound of the following formula (9) by reacting a cyclopropaneacetic acid derivative of the following formula (8) with disodium disulfide (Na 2 S 2 ), and alkali hydrolysis of the formula (1) Process for the preparation of 1- (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropane acetic acid:
Figure PCTKR2012000925-appb-I000004
Figure PCTKR2012000925-appb-I000004
상기 식에서 X는 디소듐 디설파이드와의 치환 반응에서 이탈이 용이한 염소, 브롬, 요오드와 같은 할로겐 원자 또는 메탄설포네이트, 톨루엔설포네이트와 같은 설포네이트기를 포함하고, Y는 시안기 또는 에스테르기와 같은 카복시 산 유도체로서 에스테르기는 메틸에스테르, 에틸에스테르와 같은 저급 알킬 에스테르이거나 필요시 페닐에스테르와 같은 아릴에스테르 등과 같이 가수분해가 용이한 에스테르기들을 포함한다.Wherein X is a halogen atom such as chlorine, bromine or iodine or sulfonate groups such as methanesulfonate and toluenesulfonate which are easily released in substitution reaction with disodium disulfide, and Y is carboxy such as cyan group or ester group As the acid derivative, the ester group includes ester groups that are easily hydrolyzed, such as lower alkyl esters such as methyl ester and ethyl ester or aryl esters such as phenyl ester if necessary.
디소듐 디설파이드의 치환반응에서 사용하는 용매로는 디메틸포름아미드, 디메틸설폭사이드, 테트라히드로퓨란, 디옥산 등과 같은 극성유기용매, 메탄올, 에탄올과 같은 알콜류, 아세토니트릴과 같은 니트릴류, 아세톤과 같은 케톤류 또는 이들 유기용매들의 혼합용매나 물과의 혼합 용매들을 사용한다.Solvents used in the substitution reaction of disodium disulfide include polar organic solvents such as dimethylformamide, dimethyl sulfoxide, tetrahydrofuran and dioxane, alcohols such as methanol and ethanol, nitriles such as acetonitrile and ketones such as acetone. Or mixed solvents of these organic solvents or mixed solvents with water.
본 발명의 원료물질인 반응식 2에서 화합물(8)은 공업적으로 구입이 용이한 구조식(4)의 1-(히드록시메틸)시클로프로판아세토니트릴로부터 아래의 반응식 3에서와 같이 먼저 할로겐화 또는 설폰화 반응으로 치환반응에 유리한 이탈기 X로 치환된 구조식10의 화합물을 얻어 반응식 2의 원료로 사용하거나 또는, 이렇게 합성 제조한 구조식(10)의 화합물을 염산 알콜용액에서 알콜화 하고 알칼리 중화반응으로 에스테르화하여 구조식(11)의 화합물을 제조하여 반응식 2의 원료로 사용할 수 있다.Compound (8) in Scheme 2, a raw material of the present invention, is first halogenated or sulfonated from 1- (hydroxymethyl) cyclopropaneacetonitrile of Structural Formula (4), which is commercially available, as shown in Scheme 3 below. The compound of formula 10 obtained by substitution with leaving group X, which is advantageous for the substitution reaction, is used as a raw material of Scheme 2, or the compound of formula (10) thus synthesized is alcoholized in an alcohol solution of hydrochloric acid and esterified by alkali neutralization. The compound of Structural Formula (11) can be prepared and used as a raw material of Scheme 2.
<반응식 3><Scheme 3>
Figure PCTKR2012000925-appb-I000005
Figure PCTKR2012000925-appb-I000005
반응식 3에서 X는 디소듐 디설파이드와의 치환 반응에서 이탈이 용이한 염소, 브롬, 요오드와 같은 할로겐 원자 또는 메탄설포네이트, 톨루엔설포네이트와 같은 설포네이트기를 포함한다.X in Scheme 3 includes halogen atoms such as chlorine, bromine and iodine or sulfonate groups such as methanesulfonate and toluenesulfonate that are easily released in substitution with disodium disulfide.
반응식 3에서 Y는 에스테르 및 시안기와 같은 유기산의 유도체를 말하며, 에스테르의 경우 가성소다, 탄산나트륨, 수산화 칼륨, 탄산 칼륨과 같은 무기염기로서 가수분해가 용이한 알킬 에스테르, 아릴 에스테르를 포함한다.In Scheme 3, Y refers to derivatives of organic acids such as esters and cyan groups, and esters include alkyl esters and aryl esters which are easily hydrolyzed as inorganic bases such as caustic soda, sodium carbonate, potassium hydroxide and potassium carbonate.
알킬 에스테르의 경우 산업적으로 취급이 용이한 탄소수 1~6의 알킬 에스테르가 유리하고, 아릴에스테르의 경우에는 산업적으로 취급이 용이한 페닐 또는 치환된 페닐에스테르가 유리하다.In the case of alkyl esters, industrially easy to handle alkyl esters having 1 to 6 carbon atoms are advantageous, and in the case of aryl esters, industrially easy to handle phenyl or substituted phenyl esters are advantageous.
본 발명을 쉽게 설명하는 반응식 2에서 가수분해반응에 있어서는 구조식(9)의 화합물에서 Y가 에스테르치환기일 경우에는 가성소다, 탄산나트륨,수산화 칼륨, 탄산 칼륨과 같이 공업적으로 구입이 용이한 무기염기로 가수분해하여 목적화합물인 구조식(1)의 1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산을 얻는다.In the hydrolysis reaction in Reaction Scheme 2, which is a simple description of the present invention, when Y is an ester substituent in the compound of Structural Formula (9), it is an inorganic base that is easily commercially available such as caustic soda, sodium carbonate, potassium hydroxide, and potassium carbonate. Hydrolysis yields 1- (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropaneacetic acid of Structural Formula (1) as a target compound.
반응식 2의 가수분해반응에 있어서 구조식(9)의 화합물에서 Y가 시안기일 경우에는 염산 알콜용액에서 알콜화 반응 후 가성소다, 탄산나트륨, 수산화 칼륨, 탄산 칼륨 등의 무기염기로 가수분해하여 목적화합물인 구조식(1)의 1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산을 얻는다.In the hydrolysis reaction of Scheme 2, when Y is a cyan group in the compound of formula (9), after alcoholation reaction in an alcohol solution of hydrochloric acid, it is hydrolyzed by inorganic base such as caustic soda, sodium carbonate, potassium hydroxide, potassium carbonate, etc. 1- (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropane acetic acid of formula (1) is obtained.
본 발명에서 사용하는 소듐 디설파이드는 ‘Journal of the chemical society 1930. 1473~1497’에 언급된 제조법을 활용하여 공업적으로 구입이 용이한 소듐 설파이드 수화물(Na2S2.7H20)과 황을 에탄올 용매 하에서 가열 반응하여 제조 사용하였다. Sodium disulfide used in the present invention is a commercially available sodium sulfide hydrate (Na 2 S 2 .7H 2 0) and sulfur using the manufacturing method mentioned in 'Journal of the chemical society 1930. 1473 ~ 1497'. It was prepared by heating the reaction under ethanol solvent.
이하 실시 예를 통하여 본 발명을 구체적으로 설명하나, 하기 실시 예는 본 발명의 예시일 뿐 본 발명을 여기에 한정하는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to Examples, but the following Examples are merely illustrative of the present invention and are not intended to limit the present invention.
이하 실시 예를 통하여 본 발명을 구체적으로 설명하나, 하기 실시 예는 본 발명의 예시일 뿐 본 발명을 여기에 한정하는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to Examples, but the following Examples are merely illustrative of the present invention and are not intended to limit the present invention.
실시예 1. Example 1.
1-(1’-시아노시클로프로판메틸디설파닐메틸)시클로프로판아세토니트릴의 제조Preparation of 1- (1'-cyanocyclopropanemethyldisulfanylmethyl) cyclopropaneacetonitrile
1-(히드록시메틸)시클로프로판아세토니트릴 27.8g(0.25몰)과 메탄설포닐 클로라이드 31.4g(0.275몰)을 디클로로메탄 150ml에 넣고 0℃ 에서 교반하면서 트리에틸아민 37.9g(0.375몰)을 적가한 후 0℃ 에서 약 2시간 교반한다. 가스크로마토그라피 분석으로 반응이 완결되면 5%염산수용액으로 반응액을 pH 3이하로 조절하고 층분리한다. 분리한 유기층을 5%가성소다 수용액으로 pH 7~8로 중화한 다음 층 분리하고 분리된 유기층을 H2O 100 ml로 세척한 후에 유기층을 무수망초로 수분제거한 후 여과한 다음 여액을 감압 농축하여 연한미색의 액체인 1-(메탄설포닐옥시메틸)시클로프로판아세토니트릴 23.4g(0.124몰)을 얻었다. 27.8 g (0.25 mole) of 1- (hydroxymethyl) cyclopropaneacetonitrile and 31.4 g (0.275 mole) of methanesulfonyl chloride were added to 150 ml of dichloromethane, and 37.9 g (0.375 mole) of triethylamine was added dropwise with stirring at 0 ° C. After stirring at 0 ° C. for about 2 hours. When the reaction is completed by gas chromatography analysis, the reaction solution is adjusted to pH 3 or below with 5% aqueous hydrochloric acid solution and the layers are separated. The organic layer was neutralized to pH 7-8 with 5% aqueous sodium hydroxide solution, the layers were separated, the organic layer was washed with 100 ml of H 2 O, the organic layer was removed with anhydrous forget-me-not, filtered and the filtrate was concentrated under reduced pressure. 23.4 g (0.124 mol) of 1- (methanesulfonyloxymethyl) cyclopropaneacetonitrile as a light off-white liquid were obtained.
이 농축액 22.7g (0.12몰)을 DMF 100ml에 용해하고 디소듐 디설파이드 5.45g(0.05몰)을 가한 후 90℃에서 8시간 정도 교반 반응한 다음 가스크로마토그라피 분석으로 반응완결을 확인한다. 반응액을 5%염산수용액으로 pH 3이하로 조절한 후 디클로로메탄 100ml를 가하여 추출한다. 유기층을 5% 가성소다 수용액으로 pH 7~8로 중화한 다음 유기층을 분리한다. 유기층을 무수 망초로 수분 제거시키고 여과한 후 여액을 감압 농축하여 연미색의 액상 1-(1’-시아노시클로프로판메틸디설파닐메틸)시클로프로판아세토니트릴 11.4g(0.045몰)을 얻었다.  22.7 g (0.12 mole) of this concentrate was dissolved in 100 ml of DMF, 5.45 g (0.05 mole) of disodium disulfide was added, followed by stirring at 90 ° C. for about 8 hours to confirm completion of the reaction by gas chromatography analysis. The reaction solution was adjusted to pH 3 or less with 5% aqueous hydrochloric acid solution, and extracted with 100 ml of dichloromethane. The organic layer was neutralized to pH 7-8 with 5% aqueous sodium hydroxide solution, and then the organic layer was separated. The organic layer was removed with anhydrous forget-me-not, filtered, and the filtrate was concentrated under reduced pressure to obtain 11.4 g (0.045 mol) of pale brown liquid 1- (1'-cyanocyclopropanemethyldisulfanylmethyl) cyclopropaneacetonitrile.
1H NMR (CDCl3, 300MHz) : δ 0.52-0.57 (8H, m); 2.49 (4H, s); 3.42 (4H, s)1 H NMR (CDCl 3 , 300 MHz): δ 0.52-0.57 (8H, m); 2.49 (4H, s); 3.42 (4H, s)
실시예 2.Example 2.
1-(1'-(카보메톡시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산 메틸 에스테르의 제조Preparation of 1- (1 '-(carbomethoxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropaneacetic acid methyl ester
실시예 1에서 얻은 1-(1’-시아노시클로프로판메틸디설파닐메틸)시클로프로판아세토니트릴 11.4g(0.045몰)을 염산 6.48g을 용해한 메탄올용액 100ml에 가하여 70℃ 에서 8시간 교반 반응한다. 가스크로마토그라피 분석으로 반응 완결이 확인되면 용매를 농축한 후에 디클로로메탄 100ml로 용해한다. 유기용액을 5%가성소다 수용액으로 반응의 pH를 7~8로 중화한 후에 유기층을 층 분리하고 분리된 유기층을 물 100 ml로 세척한다. 유기층을 무수 망초로 건조시킨 후에 여과하고 여액을 감압 농축하여 연미색 액체의 1-(1'-(카보메톡시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산 메틸 에스테르 25.2g(0.036몰)을 얻었다. 11.4 g (0.045 mol) of 1- (1'-cyanocyclopropanemethyldisulfanylmethyl) cyclopropaneacetonitrile obtained in Example 1 was added to 100 ml of a methanol solution in which 6.48 g of hydrochloric acid was dissolved, followed by stirring at 70 ° C. for 8 hours. . After completion of the reaction by gas chromatography analysis, the solvent is concentrated and dissolved in 100 ml of dichloromethane. After neutralizing the pH of the reaction to 7-8 with an aqueous 5% caustic soda solution, the organic layer was separated and the separated organic layer was washed with 100 ml of water. The organic layer was dried over anhydrous forget-me-not, filtered, and the filtrate was concentrated under reduced pressure to give 25.2 g (0.036 mol) of 1- (1 '-(carbomethoxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropaneacetic acid methyl ester as a pale brown liquid. Got.
1H NMR (CDCl3, 300MHz) : δ 0.50-0.62 (8H, m); 2.41 (4H, s); 2.86 (4H, s); 3.64 (6H, s)1 H NMR (CDCl 3 , 300 MHz): δ 0.50-0.62 (8H, m); 2.41 (4H, s); 2.86 (4H, s); 3.64 (6H, s)
실시예 3.Example 3.
1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산의 제조Preparation of 1- (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropaneacetic acid
실시예 2에서 얻은 1-(1'-(카보메톡시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산 메틸 에스테르 농축액을 메탄올 70ml에 용해하고 가성소다 3.1g(0.078몰)을 가하여 6시간 환류교반 반응한다. 가스크로마토 그라피 분석으로 반응물이 소모된 것이 확인되면 에틸 아세테이트 100ml와 물 200ml를 가하여 30분간 교반한 후 층 분리한다. 분리한 물층에 디클로로메탄 150ml를 가하여 5% 염산수용액으로 pH 3~4로 중화한 후에 유기층을 분리하고 무수 망초로 건조시킨 후 여과하고 여액을 감압 농축하여 미색 고체 1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산 8.7g (0.03몰)을 얻었다.The 1- (1 '-(carbomethoxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropane acetic acid methyl ester concentrate obtained in Example 2 was dissolved in 70 ml of methanol, and caustic soda 3.1 g (0.078 mol) was added to reflux for 6 hours. Stirring reaction. When gas chromatography confirmed that the reaction product was consumed, 100 ml of ethyl acetate and 200 ml of water were added thereto, stirred for 30 minutes, and the layers were separated. 150 ml of dichloromethane was added to the separated water layer and neutralized with 5% aqueous hydrochloric acid solution to pH 3-4. The organic layer was separated, dried over anhydrous forget-me-not, filtered and the filtrate was concentrated under reduced pressure to give an off-white solid 1- (1 '-(carboxymethyl). 8.7 g (0.03 mol) of cyclopropanemethyldisulfanylmethyl) cyclopropane acetic acid was obtained.
1H NMR (CDCl3, 300MHz) : δ 0.52-0.57 (8H, m); 2.27 (4H, s); 2.90 (4H, s); 12.14 (2H, s)1 H NMR (CDCl 3 , 300 MHz): δ 0.52-0.57 (8H, m); 2.27 (4H, s); 2.90 (4H, s); 12.14 (2H, s)
실시예 4.Example 4.
메틸 1-(브로모메틸)시클로프로판아세테이트를 경유하는 1-(1'-(카보메톡시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산 메틸 에스테르의 제조Preparation of 1- (1 '-(carbomethoxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropaneacetic acid methyl ester via methyl 1- (bromomethyl) cyclopropaneacetate
1-(히드록시메틸)시클로프로판아세토니트릴11.1g(0.1M)을 디클로로메탄 33ml에 용해하여 10℃ 에서 교반하면서 삼브롬화 인 27.9g (0.102M) 을 서서히 적가하고 10℃ 에서 4시간 교반한다. 가스크로마토그라피 분석으로 반응완결을 확인하고 5% 탄산나트륨 수용액으로 반응액을 중화한다. 층 분리 유기 층을 물 50 ml로 세척하고 유기 층을 무수 무수망초로 수분제거한 후에 여과하고 여액을 감압 농축하여 연미색의 1-(브로모메틸)시클로프로판아세토니트릴을 15.6g(0.089몰)을 액상으로 얻었다. 11.1 g (0.1 M) of 1- (hydroxymethyl) cyclopropaneacetonitrile is dissolved in 33 ml of dichloromethane and 27.9 g (0.102 M) of phosphorus tribromide is slowly added dropwise while stirring at 10 ° C, followed by stirring at 10 ° C for 4 hours. Confirm the reaction completion by gas chromatography analysis and neutralize the reaction solution with 5% aqueous sodium carbonate solution. The separated organic layer was washed with 50 ml of water, the organic layer was dried with anhydrous anhydrous forage, filtered and the filtrate was concentrated under reduced pressure to give 15.6 g (0.089 mol) of pale brown 1- (bromomethyl) cyclopropaneacetonitrile. Obtained in the liquid phase.
염산 25.8g을 무수 메탄올 135ml에 용해하고 앞에서 얻은 1-(브로모메틸)시클로프로판아세토니트릴을 15.6g(0.89몰)을 가하고 70℃ 에서 12시간 교반하고 가스크로마토그라피 분석으로 반응물이 전부 소모된 것을 확인한다. 반응액을 진공농축하고 디클로로메탄 180ml로 용해한 후 5 %가성소다 수용액으로 pH 7~8로 중화한다. 유기 층을 층 분리하고 무수 망초로 수분제거한 후 여과하고 여액을 감압 농축하여 연미색 액체의 메틸 1-(브로모메틸)시클로프로판아세테이트 13.1g(0.063몰)을 얻었다.   Dissolve 25.8 g of hydrochloric acid in 135 ml of anhydrous methanol, add 15.6 g (0.89 mole) of 1- (bromomethyl) cyclopropaneacetonitrile obtained above, stir at 70 ° C. for 12 hours, and exhaust the reaction product by gas chromatography analysis. Check it. The reaction solution is concentrated in vacuo, dissolved in 180 ml of dichloromethane and neutralized to pH 7-8 with 5% aqueous sodium hydroxide solution. The organic layer was separated, dried with anhydrous forget-me-not, filtered, and the filtrate was concentrated under reduced pressure to obtain 13.1 g (0.063 mol) of methyl 1- (bromomethyl) cyclopropane acetate as a pale brown liquid.
이 메틸 1-(브로모메틸)시클로프로판아세테이트 농축액과 디소듐 디설파이드 3.3g (0.03몰)을 DMF 130ml에 넣고 90℃에서 8시간 정도 교반반응한다. 가스크로마토그라피 분석으로 반응 완결을 확인하고 5 %염산 수용액으로 pH 3~4로 조절한 후에 층 분리한 유기층을 5 % 가성소다 수용액으로 pH 7~8로 중화한다. 유기층을 층 분리하고 무수 망초로 수분 제거한 후 여과한 다음 여액을 감압 농축하여 미색 액체의 1-(1'-(카보메톡시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산 메틸 에스테르 7.56g(0.024몰)을 얻었다.This methyl 1- (bromomethyl) cyclopropane acetate concentrate and 3.3 g (0.03 mol) of disodium disulfide were added to 130 ml of DMF and stirred at 90 ° C. for about 8 hours. Confirm the completion of the reaction by gas chromatography analysis, adjust the pH to 3-4 with 5% hydrochloric acid aqueous solution, and neutralize the separated organic layer to pH 7-8 with 5% aqueous sodium hydroxide solution. The organic layer was separated, dried over anhydrous forget-me-not, filtered, and the filtrate was concentrated under reduced pressure to give 7.56 g of 1- (1 '-(carbomethoxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropane acetic acid methyl ester of a liquid. 0.024 mole).
1H NMR (CDCl3, 300MHz) : δ 0.50-0.62 (8H, m); 2.41 (4H, s); 2.86 (4H, s); 3.64 (6H, s)1 H NMR (CDCl 3 , 300 MHz): δ 0.50-0.62 (8H, m); 2.41 (4H, s); 2.86 (4H, s); 3.64 (6H, s)
디소듐 디설파이드의 제조Preparation of Disodium Disulfide
소듐 설파이드 9수화물 (알드리치, 98%) 50g을 에탄올 500ml에 용해한 후 황 7.5g을 가한 후 2시간 가열 환류 반응한다. 반응액을 감압농축한 후 다시 에탄올 500ml를 가하여 감압농축하여 함유수분을 제거한 다음 생성된 고체 화합물 디소듐 디설파이드를 필요한 반응에 투입 사용한다.50 g of sodium sulfide hexahydrate (Aldrich, 98%) was dissolved in 500 ml of ethanol, and 7.5 g of sulfur was added thereto, followed by heating under reflux for 2 hours. The reaction solution was concentrated under reduced pressure, and 500 ml of ethanol was further added thereto, followed by concentration under reduced pressure to remove moisture. The resulting solid compound disodium disulfide was added to the required reaction.
1-(머캅토메틸)시클로프로판아세트산의 제조Preparation of 1- (mercaptomethyl) cyclopropaneacetic acid
실시예 3에서 얻은 1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산 8.7g (0.03몰)과 분말아연 3.8g (0.06M)을 메탄올 45ml에 넣고 교반하면서 hydrazine(4.5g, 0.09M)를 서서히 가한 후 실온에서 12시간 동안 강하게 교반 반응하고 가스크로마토그라피 분석으로반응 완결을 확인한다. 반응액을 여과하고 감압 농축한 후에 디클로로메탄100ml로 용해하고 5%염산 수용액으로 pH 7~8로 중화한다. 유기층을 층 분리하고 분리된 유기층을 무수 망초로 수분을 제거한다. 여과하고 여액을 감압 농축하여 1-(머캅토메틸)시클로프로판아세트산 3.5g(0.024몰)을 연미색 고체로 얻었다.8.7 g (0.03 mol) of 1- (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropane acetic acid obtained in Example 3 and 3.8 g (0.06 M) of powdered zinc were added to 45 ml of methanol, followed by stirring. 4.5g, 0.09M) was added slowly, followed by vigorous stirring at room temperature for 12 hours, followed by gas chromatography analysis. The reaction solution was filtered, concentrated under reduced pressure, dissolved in 100 ml of dichloromethane and neutralized to pH 7-8 with 5% aqueous hydrochloric acid solution. The organic layer is separated and the separated organic layer is dried with anhydrous forget-me-not. Filtration and concentration of the filtrate under reduced pressure afforded 3.5 g (0.024 mol) of 1- (mercaptomethyl) cyclopropane acetic acid as a pale brown solid.
1H NMR (CDCl3, 300MHz) : δ 0.54-0.64 (4H, m); 1.3 (1H, t); 2.48 (2H, d); 2.6 (2H, d)1 H NMR (CDCl 3 , 300 MHz): δ 0.54-0.64 (4H, m); 1.3 (1 H, t); 2.48 (2H, d); 2.6 (2H, d)
본 발명은 의약품, 특히 천식치료제 ‘몬테루카스트(Montelukast)'의 합성에서 중요한 중간체 1-(머캅토메틸)시클로프로판아세트산의 전구체인 1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산과 그 유도체들을 제조하는데 유용하게 이용될 수 있다. The present invention relates to 1- (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl), which is a precursor of intermediate 1- (mercaptomethyl) cyclopropaneacetic acid, which is important in the synthesis of pharmaceuticals, in particular the asthma drug' Montelukast ' It can be usefully used to prepare cyclopropane acetic acid and its derivatives.

Claims (5)

  1. 하기 구조식(8)의 시클로프로판아세트산 유도체를 디소듐 디설파이드(Na2S2)와 반응시켜 하기 구조식 (9)의 디설파이드 화합물을 제조하고 이를 알칼리 가수분해하는 것을 특징으로 하는 구조식(1)의 1-(1'-(카복시메틸)시클로프로판메틸디설파닐메틸)시클로프로판아세트산의 제조방법:1- of Structural Formula (1) characterized by reacting a cyclopropaneacetic acid derivative of Structural Formula (8) with disodium disulfide (Na 2 S 2 ) to prepare a disulfide compound of Structural Formula (9) and alkali hydrolysis thereof (1 '-(carboxymethyl) cyclopropanemethyldisulfanylmethyl) cyclopropaneacetic acid
    Figure PCTKR2012000925-appb-I000006
    Figure PCTKR2012000925-appb-I000006
    상기 식에서 X는 할로겐 원자 또는 설포네이트기이고, Y는 유기산 유도체이다.Wherein X is a halogen atom or a sulfonate group, and Y is an organic acid derivative.
  2. 제1항에 있어서, Y는 가성소다, 탄산나트륨, 수산화 칼륨, 탄산 칼륨과 같은 무기염기로서 가수분해가 용이한 알킬 에스테르 또는 아릴 에스테르인 것을 특징으로 하는 제조방법.       The method according to claim 1, wherein Y is an inorganic base such as caustic soda, sodium carbonate, potassium hydroxide or potassium carbonate, and is an alkyl ester or an aryl ester which is easily hydrolyzed.
  3. 제1항에 있어서, 디소듐 디설파이드의 치환반응에서 사용하는 용매로는 디메틸포름아미드, 디메틸설폭사이드, 테트라히드로퓨란, 디옥산 등과 같은 극성유기용매, 메탄올, 에탄올과 같은 알콜류, 아세토니트릴과 같은 니트릴류, 아세톤과 같은 케톤류 또는 이들 유기용매들의 혼합용매나 물과의혼합 용매들을 사용하는 것을 특징으로 하는 제조방법.       The solvent used in the substitution reaction of disodium disulfide is a polar organic solvent such as dimethylformamide, dimethyl sulfoxide, tetrahydrofuran, dioxane, alcohols such as methanol and ethanol, nitrile such as acetonitrile. And a ketone such as acetone, a mixed solvent of these organic solvents, or a mixed solvent with water.
  4. 제2항에 있어서, 알킬 에스테르는 탄소수 1~6의 알킬 에스테르, 아릴에스테르는 페닐 또는 치환된 페닐에스테르인 것을 특징으로 하는 제조방법.      The method according to claim 2, wherein the alkyl ester is an alkyl ester having 1 to 6 carbon atoms, and the aryl ester is phenyl or substituted phenyl ester.
  5. 제1항에 있어서, 상기 알칼리 가수분해에 사용하는 알칼리는 가성소다, 탄산나트륨, 수산화 칼륨, 탄산 칼륨, 수산화 리튬, 탄산 리튬으로 구성된 그룹으로부터 선택되는 무기염기인 것을 특징으로 하는 제조방법.       The method according to claim 1, wherein the alkali used for alkali hydrolysis is an inorganic base selected from the group consisting of caustic soda, sodium carbonate, potassium hydroxide, potassium carbonate, lithium hydroxide and lithium carbonate.
PCT/KR2012/000925 2012-01-10 2012-02-08 Method for preparing 1-(1'-(carboxymethyl)cyclopropane methyl disulfonyl methyl)cyclopropane acetic acid and derivative thereof WO2013105688A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020120003186A KR101431678B1 (en) 2012-01-10 2012-01-10 A new preparation method of 1-[1’-(Carboxymethyl)cyclopropane methyldisulfanylmethyl]cyclopropaneacetic acid and it's derivatives
KR10-2012-0003186 2012-01-10

Publications (1)

Publication Number Publication Date
WO2013105688A1 true WO2013105688A1 (en) 2013-07-18

Family

ID=48781621

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/000925 WO2013105688A1 (en) 2012-01-10 2012-02-08 Method for preparing 1-(1'-(carboxymethyl)cyclopropane methyl disulfonyl methyl)cyclopropane acetic acid and derivative thereof

Country Status (2)

Country Link
KR (1) KR101431678B1 (en)
WO (1) WO2013105688A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523477A (en) * 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
US5534651A (en) * 1993-09-03 1996-07-09 Lonza Ltd. Process for preparing γ-mercaptocarboxylic acid derivatives
US6512140B1 (en) * 2002-02-06 2003-01-28 Delmar Chemicals Inc. Process for the preparation of 1-(mercaptomethyl)-cyclopropaneacetic acid
US7572930B2 (en) * 2006-02-02 2009-08-11 Chemagis Ltd. Process for preparing 1-(mercaptomethyl)cyclopropaneacetic acid, a useful intermediate in the preparation of montelukast and salts thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534651A (en) * 1993-09-03 1996-07-09 Lonza Ltd. Process for preparing γ-mercaptocarboxylic acid derivatives
US5523477A (en) * 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
US6512140B1 (en) * 2002-02-06 2003-01-28 Delmar Chemicals Inc. Process for the preparation of 1-(mercaptomethyl)-cyclopropaneacetic acid
US7572930B2 (en) * 2006-02-02 2009-08-11 Chemagis Ltd. Process for preparing 1-(mercaptomethyl)cyclopropaneacetic acid, a useful intermediate in the preparation of montelukast and salts thereof

Also Published As

Publication number Publication date
KR20130082017A (en) 2013-07-18
KR101431678B1 (en) 2014-08-22

Similar Documents

Publication Publication Date Title
US8759525B2 (en) Process and intermediates for preparing integrase inhibitors
CA1324138C (en) Process for preparing 2-phenyl-imidazo[1,2-a,]pyridine-3-acetamide compounds and intermediate therein
KR101099995B1 (en) New process for the synthesis of strontium ranelate and its hydrates
CN105330634A (en) One-pot method for preparing 3-hydroxyphtalic anhydride
WO2011090323A2 (en) Novel preparation method of 2-(2-n-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl)-n,n-dimethylacetamide
CN113683571A (en) Preparation method of 2-methyl-5-bromopyrimidine
US9024030B2 (en) Process for the synthesis of etoricoxib
JPS63316757A (en) 3-amino-2-substituted benzoylacrylic acid derivative
WO2013105688A1 (en) Method for preparing 1-(1&#39;-(carboxymethyl)cyclopropane methyl disulfonyl methyl)cyclopropane acetic acid and derivative thereof
WO2013115595A1 (en) Method for preparing compound by novel michael addition reaction using water or various acids as additive
US20070238881A1 (en) Process for the preparation of tazarotene intermediates and use thereof for the preparation of tazarotene
KR20000075874A (en) Process for the preparation of nicotinic acids
CN106674198A (en) Preparation method for key intermediate rabeprazole thioether
CN111410654A (en) Synthesis of 3-bromo-5- (2-ethylimidazo [1,2-a ] pyridine-3-carbonyl) -2-hydroxybenzonitrile
EP3562807B1 (en) Processes for the preparation of pesticidal compounds
KR100496248B1 (en) Process for preparation of sulfonamide derivatives and crystals thereof
CN112645885B (en) Iminopyridazine derivative, preparation method and application thereof, and pesticide
CN113754562B (en) Method for synthesizing lodoxamide or diethyl ester thereof
KR101195631B1 (en) New Synthetic Method of 9-[2-phosphonomethoxyethyl]adenine
WO2018128390A1 (en) Method for producing 5-(3,6-dihydro-2,6-dioxo-4-trifluoromethyl-1(2h)-pyrimidinyl)phenylthiol compound
CN113072471B (en) Lifeiste intermediate and preparation method thereof
CN102718716A (en) Preparation method of nizofenone
US4147876A (en) Easily hydrolyzable esters of 4-(2-carboxyethyl)phenyl trans-4-aminomethylcyclohexanecarboxylate and process of use
KR860000650B1 (en) Process for the preparation of quinolone compounds
SU448641A3 (en) Method for preparing benzenesulfonylurea

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12864921

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12864921

Country of ref document: EP

Kind code of ref document: A1